000 01354 a2200409 4500
005 20250513115131.0
264 0 _c19970520
008 199705s 0 0 eng d
022 _a0014-4886
024 7 _a10.1006/exnr.1997.6418
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcRitchie, D A
245 0 0 _aSpecific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.
_h[electronic resource]
260 _bExperimental neurology
_cMar 1997
300 _a202-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBrain Diseases
_xcomplications
650 0 4 _aCell Death
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMesencephalon
_xmetabolism
650 0 4 _aMiddle Aged
650 0 4 _aNerve Degeneration
650 0 4 _aNeurons
_xmetabolism
650 0 4 _aParkinson Disease
_xcomplications
650 0 4 _aReference Values
650 0 4 _aSerotonin
_xmetabolism
650 0 4 _aTyrosine 3-Monooxygenase
_xmetabolism
700 1 _aCartwright, H R
700 1 _aHalliday, G M
773 0 _tExperimental neurology
_gvol. 144
_gno. 1
_gp. 202-13
856 4 0 _uhttps://doi.org/10.1006/exnr.1997.6418
_zAvailable from publisher's website
999 _c9107697
_d9107697